![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Escherich, Gabriele; Zur Stadt, Udo; Borkhardt, Arndt; Dilloo, Dagmar; Faber, Joerg; Feuchtinger, Tobias; Imschweiler, Thomas; Jorch, Norbert; Pekrun, Arnulf; Schmid, Irene; Schramm, Franziska; Spohn, Michael; Zimmermann, Martin und Horstmann, Martin A.
(2022):
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.
In: Haematologica, Bd. 107, Nr. 5: S. 1026-1033
Weskamm, Leonie M.; Fathi, Anahita; Raadsen, Matthijs P.; Mykytyn, Anna Z.; Koch, Till; Spohn, Michael; Friedrich, Monika; MVA MERS S Study Grp, Bart L.; Haagmans, Bart L.; Becker, Stephan; Sutter, Gerd; Dahlke, Christine und Addo, Marylyn M.
(2022):
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.
In: Cell Reports Medicine, Bd. 3, Nr. 7, 100685
Kresbach, Catena; Dorostkar, Mario M.; Suwala, Abigail K.; Wefers, Annika K.; Schweizer, Leonille; Engertsberger, Lara; Bison, Brigitte; Mynarek, Martin; Kloth-Stachnau, Katja; Spohn, Michael; Deimling, Andreas von; Benesch, Martin; Hagel, Christian; Mautner, Viktor-F.; Rutkowski, Stefan und Schueller, Ulrich
(2021):
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
In: Acta Neuropathologica, Bd. 141, Nr. 6: S. 971-974
Niesen, Judith; Ohli, Jasmin; Sedlacik, Jan; Dührsen, Lasse; Hellwig, Malte; Spohn, Michael; Holsten, Till und Schüller, Ulrich
(2020):
Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
In: Cancer Letters, Bd. 477: S. 10-18
Schoof, Melanie; Launspach, Michael; Holdhof, Dorthe; Nguyen, Lynhda; Engel, Verena; Filser, Severin; Peters, Finn; Immenschuh, Jana; Hellwig, Malte; Niesen, Judith; Mall, Volker; Ertl-Wagner, Birgit; Hagel, Christian; Spohn, Michael; Lutz, Beat; Sedlacik, Jan; Indenbirken, Daniela; Merk, Daniel J. und Schueller, Ulrich
(2019):
The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.
In: Acta Neuropathologica Communications, Bd. 7, Nr. 1, 199
Neumann, Julia E.; Spohn, Michael; Obrecht, Denise; Mynarek, Martin; Thomas, Christian; Hasselblatt, Martin; Dorostkar, Mario M.; Wefers, Annika K.; Frank, Stephan; Monoranu, Camelia-Maria; Koch, Arend; Witt, Hendrik; Kool, Marcel; Pajtler, Kristian W.; Rutkowski, Stefan; Glatzel, Markus und Schueller, Ulrich
(2019):
Molecular characterization of histopathological ependymoma variants.
In: Acta Neuropathologica, Bd. 139, Nr. 2: S. 305-318
Hellwig, Malte; Lauffer, Marlen C.; Bockmayr, Michael; Spohn, Michael; Merk, Daniel J.; Harrison, Luke; Ahlfeld, Julia; Kitowski, Annabel; Neumann, Julia E.; Ohli, Jasmin; Holdhof, Doerthe; Niesen, Judith; Schoof, Melanie; Kool, Marcel; Kraus, Cornelia; Zweier, Christiane; Holmberg, Dan und Schueller, Ulrich
(2019):
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
In: Acta Neuropathologica, Bd. 137, Nr. 4: S. 657-673
Dahlke, Christine; Kasonta, Rahel; Lunemann, Sebastian; Krähling, Verena; Zinser, Madeleine E.; Biedenkopf, Nadine; Fehling, Sarah K.; Ly, My L.; Rechtien, Anne; Stubbe, Hans C.; Olearo, Flaminia; Borregaard, Saskia; Jambrecina, Alen; Stahl, Felix; Strecker, Thomas; Eickmann, Markus; Lütgehetmann, Marc; Spohn, Michael; Schmiedel, Stefan; Lohse, Ansgar W.; Becker, Stephan und Addo, Marylyn M.
(2017):
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.
In: Ebiomedicine, Bd. 19: S. 107-118
Bialek, Julia K.; Dunay, Gábor A.; Voges, Maike; Schäfer, Carola; Spohn, Michael; Stucka, Rolf; Hauber, Joachim und Lange, Ulrike C.
(2016):
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
In: PLOS ONE 11(6), e0158294 [PDF, 2MB]
In: PLOS ONE 11(6), e0158294 [PDF, 2MB]